Orbital hemangioma.
Coats
David
D
Paysse
Evelyn A
EA
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D001706:Biopsy; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005865:Gestational Age; D018324:Hemangioma, Capillary / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007223:Infant; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D009918:Orbital Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011994:Recombinant Proteins; D012189:Retrospective Studies
D020533:Angiogenesis Inhibitors; D018906:Antineoplastic Agents, Alkylating; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D003520:Cyclophosphamide